ZHANG TING | Molecular Biology | Young Scientist Award

Published on by Molecular Biologist

Ms. ZHANG TING | Molecular Biology | Young Scientist Award 

Teacher | China Kashi University | China

Dr. Zhang Ting is a distinguished Chinese biologist specializing in biological resources, nutritional biochemistry, and translational medicine. He earned his Bachelor of Nutrition, Master’s in Nutritional Studies, and Doctor of Biology from Hoseo University, South Korea, focusing on integrative nutrition, functional foods, and systems biology. His doctoral research explored neuropharmacological mechanisms in Alzheimer’s disease, stroke, diabetes, and obesity, combining molecular assays, rodent behavioral studies, and herbal medicine bioactivity. With over a decade of laboratory experience, Zhang has worked at Hoseo University and YEJUN Institute of Biological Sciences, leading experiments on metabolic regulation, neuroprotection, and chronic disease models while mentoring junior scientists and overseeing laboratory safety. His research interests include gut-brain axis modulation, herbal and fermented food interventions, metabolic disorders, and diet-based cognitive enhancement. Zhang bridges traditional medicinal knowledge with modern translational medicine, aiming to develop innovative strategies for chronic disease mitigation. His work has been widely cited and recognized internationally, reflecting his contributions to nutritional biochemistry, neuropharmacology, and functional food research, positioning him as a rising leader in integrative biomedical science.

Profile: ORCID

Featured Publications

Zhang, T., & Park, S. (n.d.). Network pharmacology-guided discovery of traditional Chinese medicine extracts for Alzheimer’s disease: Targeting neuroinflammation and gut-brain axis dysfunction. Int J Mol Sci, 26(17), 8545. Cited by 12.

Zhang, T., & Park, S. (n.d.). Energy intake-dependent genetic associations with obesity risk: BDNF Val66Met polymorphism and interactions with dietary bioactive compounds. Antioxidants, 14(2), 170.

Zhang, T., Yue, Y., Li, C., et al. (n.d.). Vagus nerve suppression in ischemic stroke by carotid artery occlusion: Implications for metabolic regulation, cognitive function, and gut microbiome in a gerbil model. Int J Mol Sci, 25, 7831.

Zhang, T., Li, C., Yue, Y., et al. (n.d.). Fermented red pepper paste (Kochujang) modulates glucose metabolism and gut microbiota in parasympathetic suppression: Network pharmacology and in vivo study. Food Biosci, 104531.

Zhang, T., Yue, Y., Jeong, S. J., et al. (n.d.). Improvement of estrogen deficiency symptoms by long-term fermented soybeans (Doenjang) rich in Bacillus species through modulating gut microbiota in estrogen-deficient rats. Foods, 12(6), 1143.

Manuela Cappelletti | Immunology | Industry Impact Award

Published on by Molecular Biologist

Mrs. Manuela Cappelletti | Immunology | Industry Impact Award 

Senior lab biologist | TAKIS srl | Italy

Mrs. Manuela Cappelletti is an accomplished Italian Senior Laboratory Biologist with extensive experience in molecular biology, immunology, and preclinical biotechnology. She has played a key role at Takis Srl in Rome, contributing to research in monoclonal antibody generation and vaccine development. Previously, she held senior research positions at IRBM Merck Research Laboratories and RTC Research Toxicology Center, where she developed expertise in molecular cloning, cell biology, and animal experimentation. At Takis, she oversees hybridoma generation, antibody subcloning, and large-scale antibody production, ensuring high standards of biosafety and reproducibility. Her work has advanced innovative immunotherapy and vaccine platforms, including contributions to DNA-based vaccine research. With 23 scientific publications, 1,724 citations by 1,545 documents, and an h-index of 18, her research has significantly impacted the fields of antibody science and translational immunology. Renowned for her precision and leadership in laboratory innovation, Manuela continues to bridge fundamental science with applied biomedical research, fostering progress in immunotherapy and infectious disease solutions.

Profile: Scopus | ORCID

Featured Publications

Cappelletti, M., et al. (n.d.). Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein. Antibodies (Basel). Cited by 12.

Cappelletti, M., et al. (n.d.). COVID-eVax: An electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD. Molecular Therapy, 30(4). Cited by 58.

Cappelletti, M., et al. (n.d.). COVID-eVax DNA vaccine elicits protective immune responses in animal models. bioRxiv. Cited by 72.

Cappelletti, M., et al. (n.d.). Gene electro-transfer improves transduction by modifying the fate of intramuscular DNA. Journal of Gene Medicine, 5(3). Cited by 130.

Cappelletti, M., et al. (n.d.). C/EBP beta and acute phase gene regulation in liver cells. Cell Death and Differentiation, 3(2). Cited by 45.

 

Alessia Muzi | Immunology | Women Researcher Award

Published on by Molecular Biologist

Dr. Alessia Muzi | Immunology | Women Researcher Award

Principal investigator | Takis srl | Italy

Dr. Alessia Muzi is an accomplished Italian scientist and Principal Investigator at Takis Srl, leading pioneering research in oncology, monoclonal antibody engineering, and translational biotechnology. With over 20 years of experience, she has contributed significantly to therapeutic antibody development, vaccine innovation, and cancer immunotherapy. She holds a Ph.D. in Neurosciences from the University of Sacred Heart “Agostino Gemelli” and advanced degrees in Medical Biotechnology and Regulatory Medicine from the Universities of Rome “Tor Vergata” and “Sapienza.” As Head of the Monoclonal Antibody Laboratory at Takis, Dr. Muzi oversees cutting-edge projects focused on recombinant protein design and tumor-targeting antibodies. Her research bridges molecular biology and clinical applications, aiming to enhance the efficacy of cancer treatments and immunotherapies. Recipient of the FISA-2022-00899 Award for bispecific antibody development, she has co-authored 33 publications with an h-index of 20 and 1,121 citations across 1,018 documents. Dr. Muzi’s scientific leadership, regulatory expertise, and commitment to translational medicine have established her as a leading figure in Italian biomedical innovation and a driving force in advancing therapeutic strategies for oncology and infectious diseases.

Profile: Scopus | ORCID

Featured Publications

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity. (2025). Antibodies. Cited by 12.

Isolation and Characterization of Neutralizing Monoclonal Antibodies Against SARS-CoV-2 Spike Protein. (2024). Antibodies. Cited by 25.

A Linear DNA Vaccine Candidate Encoding SARS-CoV-2 RBD in Domestic Cats. (2023). Mol Ther Methods Clin Dev. Cited by 9.

A First-in-Human Trial of COVID-eVax DNA Vaccine. (2022). Mol Ther. Cited by 40.

Persistent B Cell Memory After SARS-CoV-2 Vaccination. (2022). Cell Host Microbe. Cited by 58.

COVID-eVax: Electroporated DNA Vaccine Candidate Encoding SARS-CoV-2 RBD. (2022). Mol Ther. Cited by 65.

The Nuts and Bolts of SARS-CoV-2 Spike RBD Heterologous Expression. (2021). Biomolecules. Cited by 33.

FABIANA FOSCA FERRARA | Immunology | Best Industrial Research Award

Published on by Molecular Biologist

Dr. Fabiana Fosca | Immunology | Best Industrial Research Award 

Senior Researcher | Takis srl | Italy

Dr. Fabiana Fosca Ferrara has earned distinguished recognition for her outstanding contributions to molecular biology and translational research. She was honored with the Best Ph.D. Thesis of the Year in Italy by FISV – Federazione Italiana Scienze della Vita, acknowledging her pioneering work in morphogenetic and cytological sciences. At Takis Srl, she has been an integral member of award-winning research teams advancing vaccine and antibody innovation in preclinical oncology and immunotherapy. Her FELASA European certifications and continuous professional training demonstrate her strong commitment to scientific integrity, regulatory compliance, and humane research practices. Dr. Ferrara has also played a key role in several European-funded projects and intellectual property developments that promote biomedical advancement. With 2,154 citations from 1,898 documents, 19 publications, and an h-index of 14, she exemplifies a career defined by research excellence, ethical leadership, and sustained impact in biotechnology and life sciences.

Profile: Scopus| ORCID

Featured Publications

Ferrara, F. F., et al. “Novel humanized anti-HER3 antibodies: Structural characterization and therapeutic activity.” Antibodies. – Cited by 12.

Ferrara, F. F., et al. “Isolation and characterization of neutralizing monoclonal antibodies against SARS-CoV-2 spike protein.” Antibodies. – Cited by 25.

Ferrara, F. F., et al. “COVID-eVax, an electroporated DNA vaccine candidate encoding SARS-CoV-2 RBD.” Molecular Therapy. – Cited by 180.

Ferrara, F. F., et al. “Novel benzazole derivatives endowed with potent antiheparanase activity.” Journal of Medicinal Chemistry. – Cited by 92.

Ferrara, F. F., et al. “Histone deacetylase-targeted treatment restores retinoic acid signaling in AML.” Cancer Research. – Cited by 550.

 

Junil Yoo | Biotechnology | Best Researcher Award

Published on by Molecular Biologist

Prof. Junil Yoo | Biotechnology | Best Researcher Award 

Prof. Junil Yoo | Inha university | South Korea

Prof. Jun-Il Yoo is an accomplished orthopedic surgeon and academic leader serving as Associate Professor at Inha University Hospital. His expertise encompasses geriatric orthopedics, sarcopenia, and bone health, with a strong focus on integrating artificial intelligence into musculoskeletal diagnostics and care. He has made significant contributions to orthopedic biomechanics and AI-based imaging, enhancing diagnostic precision and rehabilitation outcomes. Dr. Yoo’s education includes medical and doctoral degrees from Chung-Ang University and Chung-Buk National University, where he specialized in musculoskeletal medicine and clinical biomechanics. His professional experience spans leading roles at Gyeongsang National University Hospital, Seoul National University Bundang Hospital, and Chung-Buk National University Hospital, combining surgical excellence with academic mentorship. His research explores AI-driven body composition analysis, automated muscle segmentation, and predictive modeling for mobility in aging populations. Dr. Yoo’s numerous honors, including awards from national orthopedic and sarcopenia societies, reflect his innovative contributions to precision orthopedics and his commitment to improving patient care through advanced research and technology integration.

Profile: Google Scholar

Featured Publications

Kim, S. J., et al. Aging Clinical and Experimental Research. “Cross-sectional study comparing smart insoles and manual methods for short physical performance battery in hip fracture patients.” Cited by 12 articles.

Cha, Y. H., et al. Clinics in Orthopedic Surgery. “Comparing Stability, Gait, and Functional Score after Dual-Mobility Hip Arthroplasty.” Cited by 8 articles.

Kim, H. S., et al. PLOS One. “Correlation between thigh muscle volume and grip strength with automated segmentation.” Cited by 15 articles.

Ahn, S. H., et al. Scientific Reports. “Clinical outcomes of COVID-19 infection in patients with osteoporosis.” Cited by 22 articles.

Lee, S. Y., & Yoo, J. I. Journal of Ethnic Foods. “Soybean isoflavones potentially prevent sarcopenia: a systematic review.” Cited by 10 articles.

 

Seyithan TAYSI | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Seyithan TAYSI | Molecular Biology | Best Researcher Award 

Professor | Gaziantep University | Turkey

Prof. Dr. Seyithan Taysi is a distinguished Professor of Medical Biochemistry at Gaziantep University, widely recognized for his pioneering work on oxidative stress, antioxidant mechanisms, free radicals, and molecular oncology. He earned his Ph.D. in Medical Biochemistry from Atatürk University, where his research on oxidative mechanisms and cellular stress regulation received the Jury’s Special Award for Best Article. Currently, he leads advanced biochemical research and teaching programs, having completed over ninety-five funded projects and holding six patents. His editorial service includes roles on international journal boards such as BioMed Research International and the International Journal of Clinical and Experimental Ophthalmology, where he has reviewed more than four hundred manuscripts. Prof. Taysi’s research focuses on oxidative and nitrosative stress, the Nrf2/Keap1 pathway, and antioxidant-based therapies, integrating biochemical and molecular approaches to improve cancer treatment and radioprotection. He has 162 documents cited by 3,969 documents, with 5,099 citations and an h-index of 39, reflecting his global influence and impact in biomedical research.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Taysi, S., et al. Oxidative stress modulation in cancer therapy. Free Radical Biology & Medicine. Cited by 45 articles.

Taysi, S., et al. Phytotherapeutic agents against radiation-induced cellular damage. Antioxidants (Basel). Cited by 38 articles.

Taysi, S., et al. Nrf2/Keap1 pathway as a therapeutic target in oxidative diseases. Frontiers in Molecular Biosciences. Cited by 62 articles.

Taysi, S., et al. Role of antioxidants in radiotherapy protection. BioMed Research International. Cited by 55 articles.

Taysi, S., et al. Oxidative stress biomarkers in cancer patients. Clinical Biochemistry. Cited by 97 articles.

Anastasia Stergioula | Cancer Biology | Best Researcher Award

Published on by Molecular Biologist

Dr. Anastasia Stergioula | Cancer Biology | Best Researcher Award 

Radiation Oncologist | National and Kapodistrian University of Athens | Greece

Dr. Anastasia Stergioula is a distinguished Radiation Oncologist with extensive clinical and research experience in advanced oncological treatments. She has been instrumental in implementing precision radiotherapy techniques, including IMRT, VMAT, SRS, SBRT, and brachytherapy, bridging medical innovation and patient care. Her research focuses on hypofractionated radiotherapy, re-irradiation strategies, and pathological responses in sarcoma patients, contributing to the development of safer and more effective treatments. Dr. Stergioula earned her medical degree and specialized training in radiation oncology, complemented by advanced studies in nanomedicine and translational oncology. She has served in leading hospitals and private centers, managing complex cases and participating in international clinical trials. Her academic contributions include multiple peer-reviewed publications and presentations at major international conferences. Her work has been recognized for advancing personalized oncological care, particularly in sarcomas, lung cancers, and rare tumors. With citations from 39 documents, 10 published articles, and an h-index of 4, Dr. Stergioula demonstrates a blend of clinical excellence, research impact, and commitment to innovation, making her a strong candidate for awards recognizing outstanding contributions in radiation oncology.

Profile: Scopus | ORCID

Featured Publications

Moutsatsos, A., Cotrutz, C., Stergioula, A., Tuleasca, C., & Pantelis, E. (n.d.). Time-resolved biological effective dose distributions in stereotactic radiosurgery for vestibular schwannomas. Physics in Medicine & Biology.

Laura Estrada | Molecular Biology | Best Researcher Award

Published on by Molecular Biologist

Prof. Laura Estrada | Molecular Biology | Best Researcher Award 

Researcher | Physics department University of Buenos Aires | Argentina

Prof. Laura Cecilia Estrada is a physicist, educator, and researcher whose work bridges advanced optical microscopy, nanotechnology, and interdisciplinary biophysics. She serves as Adjunct Professor at the Department of Physics, University of Buenos Aires and Independent Researcher at CONICET, where she leads pioneering investigations in fluorescence spectroscopy, nanoimaging, and virus-host interactions. Estrada completed her academic training in physics at the University of Buenos Aires, earning her Licenciatura and Ph.D. with highest distinction, and later expanded her expertise as a postdoctoral researcher and group leader at the University of California, Irvine. Her research focuses on fluorescence-based techniques, single-particle tracking, and nano-optics applied to both fundamental physics and biomedical sciences, with special emphasis on dengue and Zika virus proteins. Alongside her scientific contributions, she has played key leadership roles in professional societies and gender equity initiatives. Her work has been recognized nationally and internationally, including awards from the International Commission for Optics, the Biophysical Society, and Argentina’s INNOVAR program. She has supervised numerous theses, mentored young scientists, and fostered international collaborations. With 35 publications, 325 citations, and an h-index of 9, Estrada exemplifies scientific rigor, innovation, and social commitment in advancing both knowledge and equity.

Profile: Scopus

Featured Publications

Sallaberry, I., & Estrada, L. Unraveling viral protein-host membrane interaction for dengue and Zika. Biophysical Journal.

Leon, A., Sallaberry, I., Estrada, L., & Scorticati, C. Non-synonymous SNPs within GPM6A impair hippocampal neuron development. Biochimica et Biophysica Acta, 1872(3). Cited by 2.

Salzman, V., & Estrada, L. Replicative lifespan determination of yeast using microfluidic chip. Biology Open, 13(11). Cited by 5.

Gaggioli, E., Estrada, L., & Bruno, O. Boundary layer structures in transport theory. Physical Review E, 110. Cited by 3.

Philipp, N., Gratton, E., & Estrada, L. Protein-membrane interaction via radial FCS. Methods and Applications in Fluorescence, 11(4). Cited by 12.

Gabriel, M., & Estrada, L. Dengue Virus Capsid Protein Dynamics in live cells. Scientific Reports, 10. Cited by 45.